Yupei You

Yupei You

Auto-generated profile, based on publicly available information

Yupei You

The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2025 in bioRxiv
Verified
Preprint
Open access
YYYupei You
Yupei You
ASAshleigh N. Solano
Ashleigh N. Solano
JLJames Lancaster
James Lancaster
MDMargaux David
Margaux David
CWChangqing Wang
Changqing Wang
MRMatthew E. Ritchie
Matthew E. Ritchie
Long-read RNA sequencing enables full-length transcript profiling and improved isoform resolution, but variable platforms and evolving chemistries demand careful benchmarking for reliable application. We present LongBench , a matched, multi-platform reference dataset spanning bulk, single-cell, and single-nucleus transcriptomics across eight human lung cancer cell lines with synthetic spike-in controls. LongBench in-corporates three state-of-the-art long-read protocols alongside Illumina short reads: Oxford Nanopore Technologies (ONT) PCR-cDNA, ONT direct RNA, and PacBio Kinnex. We systematically evaluate transcript capture, quantification accuracy, differential expression, isoform usage, variant detection, and allele-specific analyses. Our results show high concordance in gene-level differential analyses across protocols, but reduced consistency for transcript-level and isoform analyses due to length- and platform-dependent biases. Single-cell long-read data are highly concordant with bulk for high-confidence features, though single-nuclei data show reduced feature detection. LongBench provides one of the largest publicly available long-read benchmarking resources, enabling rigorous cross-platform evaluation and guiding technology selection for transcriptomic research.

23 September 2025 in Genome Biology
Verified
Journal Article
Open access
PDF file
RPRicardo De Paoli-Iseppi
Ricardo De Paoli-Iseppi
SJShweta S. Joshi
Shweta S. Joshi
JGJosie Gleeson
Josie Gleeson
YPYair D. J. Prawer
Yair D. J. Prawer
YYYupei You
Yupei You
MCMichael B. Clark
Michael B. Clark
Background: Neuropsychiatric disorders are highly complex conditions and the risk of developing a disorder has been tied to hundreds of genomic variants that alter the expression and/or RNA isoforms made by risk genes. However, how these genes contribute to disease risk and onset through altered expression and RNA splicing is not well understood. Results: Combining our new bioinformatic pipeline IsoLamp with nanopore long-read amplicon sequencing, we deeply profile the RNA isoform repertoire of 31 high-confidence neuropsychiatric disorder risk genes in Human brain. We show most risk genes are more complex than previously reported, identifying 363 novel isoforms and 28 novel exons, including isoforms which alter protein domains, and genes such as ATG13 and GATAD2A where most expression was from previously undiscovered isoforms. The greatest isoform diversity is detected in the schizophrenia risk gene ITIH4. Mass spectrometry of brain protein isolates confirms translation of a novel exon skipping event in ITIH4, suggesting a new regulatory mechanism for this gene in the brain. Conclusions: Our results emphasize the widespread presence of previously undetected RNA and protein isoforms in the human brain and provide an effective approach to address this knowledge gap. Uncovering the isoform repertoire of candidate neuropsychiatric risk genes will underpin future analyses of the functional impact these isoforms have on neuropsychiatric disorders, enabling the translation of genomic findings into a pathophysiological understanding of disease.

23 February 2024 in medRxiv
Verified
Preprint
Open access
PDF file
RPRicardo De Paoli-Iseppi
Ricardo De Paoli-Iseppi
SJShweta Joshi
Shweta Joshi
JGJosie Gleeson
Josie Gleeson
YPYair David Joseph Prawer
Yair David Joseph Prawer
YYYupei You
Yupei You
MCMichael Ben Clark
Michael Ben Clark
Neuropsychiatric disorders are highly complex conditions and the risk of developing a disorder has been tied to hundreds of genomic variants that alter the expression and/or products (isoforms) made by risk genes. However, how these genes contribute to disease risk and onset through altered expression and RNA splicing is not well understood. Combining our new bioinformatic pipeline IsoLamp with nanopore long-read amplicon sequencing, we deeply profiled the RNA isoform repertoire of 31 high-confidence neuropsychiatric disorder risk genes in human brain. We show most risk genes are more complex than previously reported, identifying 363 novel isoforms and 28 novel exons, including isoforms which alter protein domains, and genes such as ATG13 and GATAD2A where most expression was from previously undiscovered isoforms. The greatest isoform diversity was present in the schizophrenia risk gene ITIH4 . Mass spectrometry of brain protein isolates confirmed translation of a novel exon skipping event in ITIH4, suggesting a new regulatory mechanism for this gene in brain. Our results emphasize the widespread presence of previously undetected RNA and protein isoforms in brain and provide an effective approach to address this knowledge gap. Uncovering the isoform repertoire of neuropsychiatric risk genes will underpin future analyses of the functional impact these isoforms have on neuropsychiatric disorders, enabling the translation of genomic findings into a pathophysiological understanding of disease.

16 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
YYYupei You
Yupei You
YPYair D.J. Prawer
Yair D.J. Prawer
RPRicardo De Paoli-Iseppi
Ricardo De Paoli-Iseppi
CHCameron P.J. Hunt
Cameron P.J. Hunt
CPClare L. Parish
Clare L. Parish
MCMichael B. Clark
Michael B. Clark
Single-cell RNA sequencing (scRNA-seq) has revolutionised our ability to profile gene expression. However, short-read (SR) scRNAseq methodologies such as 10x are restricted to sequencing the 3’ or 5’ ends of transcripts, providing accurate gene expression but little information on the RNA isoforms expressed in each cell. Newly developed long-read (LR) scRNA-seq enables the quantification of RNA isoforms in individual cells but LR scRNA-seq using the Oxford Nanopore platform has largely relied upon matched short-read data to identify cell barcodes and allow single cell analysis. Here we introduce BLAZE (Barcode identification from long-reads for AnalyZing single-cell gene Expression), which accurately and efficiently identifies 10x cell barcodes using only nanopore LR scRNA-seq data. We compared BLAZE to existing tools, including cell barcodes identified from matched SR scRNA-seq, on differentiating stem cells and 5 cancer cell lines. BLAZE outperforms existing tools and provides a more accurate representation of the cells present in LR scRNA-seq than using matched short-reads. BLAZE provides accurate cell barcodes over a wide range of experimental read depths and sequencing accuracies, while other methodologies commonly identify false-positive barcodes and cell clusters, disrupting biological interpretation of LR scRNA-seq results. In conclusion, BLAZE eliminates the requirement for matched SR scRNA-seq to interpret LR scRNA-seq, simplifying procedures and decreasing costs while also improving LR scRNA-seq results. BLAZE is compatible with downstream tools accepting a cell barcode whitelist file and is available at https://github.com/shimlab/BLAZE .

20 October 2025 in bioRxiv
Verified
Preprint
Open access
CWChangqing Wang
Changqing Wang
YPYair D.J. Prawer
Yair D.J. Prawer
OVOliver Voogd
Oliver Voogd
JSJakob Schuster
Jakob Schuster
CPCamilla Pasquali
Camilla Pasquali
YYYupei You
Yupei You
Long-read single-cell RNA-sequencing enables the profiling of RNA isoform expression and alternative splicing at single cell resolution. However, diverse single-cell technologies and sparse isoform data demand flexible and accurate analysis tools. We introduce FLAMESv2 , a highly modular and protocol-agnostic R/Bioconductor package for long-read single-cell RNA-seq data analysis. FLAMESv2 supports a wide range of single-cell and spatial protocols, is highly configurable, scales to allow multi-sample analysis and provides versatile visualisation and analysis outputs. We demonstrate its compatibility with both droplet-based and combinatorial barcoding single-cell methods, as well as spatial transcriptomics workflows. Benchmarking confirms FLAMESv2 achieves field-leading performance across key analysis tasks. Applying FLAMESv2 to in vitro differentiation of stem cells into neurons, we identify cell-types, differentiation trajectories, expression of annotated and novel isoforms and isoform expression diversity and heterogeneity within individual cells. FLAMESv2 provides a comprehensive, flexible approach to analysing long-read single-cell RNA-sequencing, unlocking this powerful methodology for RNA isoform characterisation.

1 November 2024 in Data in Brief
Verified
Journal Article
Open access
DBDaniel V Brown
Daniel V Brown
ASAgnieszka Swierczak
Agnieszka Swierczak
YYYue You
Yue You
YYYupei You
Yupei You
DZDaniela Bettina Zalcenstein
Daniela Bettina Zalcenstein
RBRory Bowden
Rory Bowden
Single-cell RNA sequencing (scRNA-seq) is a powerful technology that enables the measurement of gene expression in individual cells. Such precision provides insights into cellular heterogeneity that bulk methods might overlook. Fragile cells, in particular neutrophils, have posed significant challenges for scRNA-Seq due to their ex vivo fragility, high RNase content and consequent loss during cryopreservation. The introduction of fixed scRNA-Seq methodology offers a promising solution to these challenges. We evaluated the performance of two different commercial platforms on red blood cell-depleted whole blood cells: 10x Genomics Flex v1 and Honeycomb HIVE v1.